Treatment of BV With First Deqularum and Then Direkt After Clindamycin
Overview
Treatment of BV with first deqularum cloride and then followed with clindamycin vaginal Cream.
Full Title of Study: “Treatment of BV With First Deqularum and Then Direkt After With Vaginal Clindamycin Cream.”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: N/A
- Intervention Model: Single Group Assignment
- Primary Purpose: Treatment
- Masking: None (Open Label)
- Study Primary Completion Date: August 1, 2021
Detailed Description
The hypoteses is that deqularum cloride takes away the biofilm so that clindamycin will kills the bacteria. Cure rate will be followed up after 1 month and then after 6 month
Interventions
- Drug: treatment of BV with first Deqularum and then direkt after with vaginal clindamycin
- All patients will get the same treatment
Arms, Groups and Cohorts
- Other: treatment of BV
- all patients be treated with first Deqularum then with clindamycin Cream,
Clinical Trial Outcome Measures
Primary Measures
- cure of BV
- Time Frame: 6 month
- cure rate of BV
Participating in This Clinical Trial
Inclusion Criteria
- healthy women with BV Exclusion Criteria:
- women treated with antibiotics within 1 month
Gender Eligibility: Female
Minimum Age: 18 Years
Maximum Age: 45 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Skaraborg Hospital
- Provider of Information About this Clinical Study
- Principal Investigator: Per-Goran Larsson, professor – Skaraborg Hospital
- Overall Official(s)
- P-G Larsson, Principal Investigator, professor
- Overall Contact(s)
- P-G Larsson, +46500431000, p-g.larsson@vgregion.se
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.